Catherine C. Reed
Catherine C. Reed publishes mostly in Psychiatry and Mental health, Economics and Econometrics and Physiology, on topics such as Dementia and Cognitive Impairment Research, Bipolar Disorder and Treatment and Schizophrenia research and treatment.
- World rank
- #436,629 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #38,412 of 367,258
- Works
- 159
- Citations
- 4.7k
- Citations per work
- 29.6
What does Catherine C. Reed research?
Catherine C. Reed's work is mostly in Medicine (40%), Economics, Econometrics and Finance (5%), Psychology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7446.4%
- Health Sciences7043.8%
- Medicine6339.7%
- Health Professions74.1%
- Social Sciences169.8%
- 1Psychiatry and Mental health31% of their works
- 2Economics and Econometrics5% of their works
- 3Physiology5% of their works
- 4Pharmacology4% of their works
- 5Clinical Psychology4% of their works
- 6General Health Professions4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Alzheimer's disease research and treatments
- Psoriasis: Treatment and Pathogenesis
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
Which keywords describe Catherine C. Reed's research?
The keywords of their largest research topics: Neuroimaging, Alzheimer's Disease, Bipolar Spectrum Disorder, Mild Cognitive Impairment, Prevalence, Antipsychotic Drugs, Neurocognitive Deficits and Depression.
- Serotonin Syndrome
- Ketamine
- TH17 Cells
- Tau Pathology
- Quality of Life
- Depression
- Antipsychotic Drugs
- Mild Cognitive Impairment
- Alzheimer's Disease
- Neuroimaging
- Bipolar Spectrum Disorder
- Prevalence
- Neurocognitive Deficits
- Cost-effectiveness Analysis
- Amyloid Hypothesis
- IL-17
- Antidepressant
- Electroconvulsive Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Neuroimaging782 topics
- Alzheimer's Disease391 topic
- Bipolar Spectrum Disorder391 topic
- Mild Cognitive Impairment391 topic
- Prevalence391 topic
- Antipsychotic Drugs281 topic
- Neurocognitive Deficits281 topic
- Depression242 topics
- Cost-effectiveness Analysis191 topic
- Quality of Life191 topic
- Amyloid Hypothesis161 topic
- Tau Pathology161 topic
- IL-17141 topic
- TH17 Cells141 topic
- Antidepressant131 topic
- Ketamine131 topic
- Electroconvulsive Therapy111 topic
- Serotonin Syndrome111 topic
Where does Catherine C. Reed work?
Catherine C. Reed's main affiliation in the publication record is Eli Lilly (United Kingdom), United Kingdom.
How many publications and citations does Catherine C. Reed have?
OpenAlex counts 159 works and 4,699 citations for Catherine C. Reed, an h-index of 41, ranking #436,629 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Catherine C. Reed. Posts are plain text and can be reported.